Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5061-5064, September 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshimoto, K.
Right arrow Articles by Itakura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshimoto, K.
Right arrow Articles by Itakura, M.

Role of p53 Mutations in Endocrine Tumorigenesis: Mutation Detection by Polymerase Chain Reaction-Single Strand Conformation Polymorphism1

Katsuhiko Yoshimoto, Hiroyuki Iwahana, Ayumi Fukuda, Toshiaki Sano, Shiro Saito and Mitsuo Itakura2

Otsuka Department of Clinical and Molecular Nutrition [K. Y., H. I., A. F., M. I.]; the First Department of Pathology [T. S.]; and the First Department of Internal Medicine [S. S.]; School of Medicine, The University of Tokushima, 3-18-15 Kuramoto-cho, Tokushima 770, Japan

To elucidate the molecular basis for endocrine tumorigenesis, p53 mutations in human endocrine tumors were analyzed by using polymerase chain reaction-single strand conformation polymorphism. Exons 5 through 10 of the p53 gene were studied in genomic DNAs from 134 primary endocrine tumors and 6 human endocrine cancer-derived cell lines. Mutations were detected and identified in 4 endocrine tumors, including one parathyroid adenoma and three thyroid carcinoma cell lines. The sites of these mutations were in exons 5 (codon 151 and 152) and 7 (codon 248 and 255). In all of three tumor cell lines, but not in a parathyroid adenoma, the normal allele encoding the p53 gene was lost. However, p53 mutations were not found in any other endocrine tumors or cell lines. Based upon these results, we concluded that the p53 gene may play a role in the tumorigenesis of a limited number of parathyroid adenoma and thyroid cancers, and that the p53 mutation with an allelic loss of the p53 gene is an important factor in malignant tumorigenesis of the thyroid gland.

1 This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan, and by a grant from Otsuka Pharmaceutical Factory, Inc., for Otsuka Department of Clinical and Molecular Nutrition, School of Medicine, The University of Tokushima.

2 To whom requests for reprints should be addressed at Otsuka Department of Clinical and Molecular Nutrition, School of Medicine, The University of Tokushima, 3-18-15 Kuramoto-cho, Tokushima 770, Japan.

Received 4/ 6/92. Accepted 7/ 7/92.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
C. S. Mitsiades, V. Poulaki, C. McMullan, J. Negri, G. Fanourakis, A. Goudopoulou, V. M. Richon, P. A. Marks, and N. Mitsiades
Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer
Clin. Cancer Res., May 15, 2005; 11(10): 3958 - 3965.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Lubomierski, M. Kersting, T. Bert, K. Muench, U. Wulbrand, M. Schuermann, D. Bartsch, and B. Simon
Tumor Suppressor Genes in the 9p21 Gene Cluster Are Selective Targets of Inactivation in Neuroendocrine Gastroenteropancreatic Tumors
Cancer Res., August 1, 2001; 61(15): 5905 - 5910.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Serrano, S. U. Goebel, P. L. Peghini, I. A. Lubensky, F. Gibril, and R. T. Jensen
Alterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4146 - 4156.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. C. Chung, S. B. Brown, F. Graeme-Cook, M. Seto, A. L. Warshaw, R. T. Jensen, and A. Arnold
Overexpression of Cyclin D1 Occurs Frequently in Human Pancreatic Endocrine Tumors
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4373 - 4378.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. L. Asa and S. Ezzat
The Cytogenesis and Pathogenesis of Pituitary Adenomas
Endocr. Rev., December 1, 1998; 19(6): 798 - 827.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Tanaka, K. Yoshimoto, P. Yang, T. Kimura, S. Yamada, M. Moritani, T. Sano, and M. Itakura
Infrequent Mutations of p27Kip1 Gene and Trisomy 12 in a Subset of Human Pituitary Adenomas
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3141 - 3147.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
H Iwahana, K Adzuma, Y Takahashi, R Katashima, K Yoshimoto, and M Itakura
Multiple fluorescence-based PCR-SSCP analysis with postlabeling.
Genome Res., April 1, 1995; 4(5): 275 - 282.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.